PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma
Open Access
- 31 March 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (4) , 614-618
- https://doi.org/10.1016/j.ejca.2003.11.016
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (13557227, 2001-2)
This publication has 9 references indexed in Scilit:
- Cancer-Specific mRNAs in Thyroid Carcinomas: Detection, Use, and Their Implication in Thyroid Carcinogenesis.Endocrine Journal, 2002
- PGP9.5 As a Candidate Tumor Marker for Non-Small-Cell Lung CancerThe American Journal of Pathology, 1999
- Protein Gene Product 9.5 is Expressed by Fibroblasts in Human Cutaneous WoundsJournal of Investigative Dermatology, 1998
- The ubiquitin-proteasome pathway in cancerBritish Journal of Cancer, 1998
- Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroidJournal of Endocrinology, 1997
- UBIQUITIN-DEPENDENT PROTEIN DEGRADATIONAnnual Review of Genetics, 1996
- PGP9.5, a ubiquitin C-terminal hydrolase; pattern of mRNA and protein expression during neural development in the mouseDevelopmental Brain Research, 1995
- The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal HydrolaseScience, 1989
- Medullary carcinoma of the thyroid glandCancer, 1975